Biogen Q3 Non-GAAP Earnings Fall, Revenue Rises

06:44 AM EDT, 10/28/2026 (MT Newswires) -- Biogen (BIIB) reported Q3 non-GAAP earnings Wednesday of $2.62 per diluted share, down from $4.81 a year earlier. Analysts polled by FactSet expected $1.99. Revenue for the quarter ended Sept. 30 was $2.80 billion, up from $2.54 billion a year earlier. Analysts expected revenue of $2.63 billion. The company expects full-year non-GAAP earnings of $12.20 to $13 per diluted share, versus $12 to $13 previously. Analysts surveyed by FactSet expect $12.34. Biogen expects full-year revenue to rise by a mid-single-digit percentage.